DRMAW
Dermata Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD0.01
+0.00 (+30.34%)
Rating:B-
Company Profile
CEO
Gerald T. Proehl
IPO Date
2021-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$0.02
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.02
52W Low
$0.01
52W High
$0.02
Market Cap
$0.00B
Volume
0.00M